We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Stryker Worldwide

evelops medical products and technologies, including Implants (joint replacement), Trauma, Craniomaxillofacial, Spina... read more Featured Products: More products

Download Mobile App




Ultrasonic Technology Augments Soft Tissue Fixation

By HospiMedica International staff writers
Posted on 10 Aug 2016
A new bioresorbable implant utilizes ultrasonic energy to liquefy and flow into cancellous bone to provide stable soft tissue to bone fixation.

The Stryker (Kalamazoo, MI, USA) SonicAnchor is a bioresorbable implant made of poly-L-DL-lactic acid (PLDLLA), which is placed into a hole drilled into the cancellous bone. More...
Once high frequency, low amplitude ultrasonic energy is applied to liquefy the tip of the implant, PLDLLA flows into the bone cavities. Following cessation of the ultrasound pulse, the material re-solidifies and hardens, providing stable three-dimensional (3D) anchoring within five seconds.

The SonicAnchor is intended for suture or tissue fixation in foot, ankle, knee, hand, wrist, elbow, and shoulder open procedures. Examples include Achilles tendon repair, lateral and medial stabilization, hallux valgus reconstruction, midfoot reconstruction, metatarsal ligament repair, and digital tendon transfer. Even with its small, 2.5 mm diameter footprint, the SonicAnchor demonstrates significant enhancement in dynamic load stability, lower risk of breakage during insertion, and high pull out strength and reliability.

“Stryker is helping drive innovation in the industry with SonicAnchor and its unique fixation technology,” said orthopedic surgeon Adam Schiff, MD, of Loyola University Medical Center (Maywood, IL, USA), who has performed several procedures using the product. “Every time I place one, I am truly impressed by the strength and performance of this small implant.”

“SonicAnchor is transforming the soft tissue experience, and we are excited Stryker is leading the way in providing this innovative solution to orthopedic surgeons,” said Tom Popeck, vice president and general manager of Stryker's Foot and Ankle business unit. “SonicFusion technology is unlike any other on the market.”

Polylactide is biodegradable thermoplastic aliphatic polyester derived from renewable resources, such as cornstarch, tapioca roots, or sugarcane. It can be processed by extrusion, 3D printing, injection molding, film and sheet casting, and spinning, providing access to a wide range of products. Since it degrades into innocuous lactic acid, it is often used in surgery in the form of anchors, screws, plates, pins, rods, and as a mesh. Depending on the exact type used, it breaks down inside the body within 6 months to 2 years.

Related Links:
Stryker



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.